NCT00718289View on ClinicalTrials.gov

Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Haemodialysis
Interventions
OTHER

Citrate dialysate

dialysis fluid composition for Citrate (C) and Acetate (A): acetate \[3.0 mmol/L in A and 0.3 in C\], citrate \[0 mmol/L in A and 0.8 in C\]

OTHER

Acetate dialysate

dialysis fluid composition for Citrate (C) and Acetate (A): acetate \[3.0 mmol/L in A and 0.3 in C\], citrate \[0 mmol/L in A and 0.8 in C\]

Trial Locations (1)

6600

Ospedale Regionale di Locarno, Locarno

All Listed Sponsors
collaborator

Bichsel AG, Interlaken, Switzerland

UNKNOWN

lead

Ospedale Regionale di Locarno

OTHER

NCT00718289 - Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes | Biotech Hunter | Biotech Hunter